Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current Practice

Serkan Doğan,Martin J.P. Hennig,Tanja Frank,J. P. Struck,A. Cebulla,J. Salem,H. Borgmann,Tobias Klatte,Axel S. Merseburger,Mario W. Kramer,Sebastian L. Hofbauer

Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current Practice

2018

Serkan Doğan
Martin J.P. Hennig
Tanja Frank
J. P. Struck
A. Cebulla
J. Salem
H. Borgmann
Tobias Klatte
Axel S. Merseburger
Mario W. Kramer
Sebastian L. Hofbauer

Background: Guidelines support the use of neoadjuvant (NAC) and adjuvant (AC) chemotherapy in muscle-invasive bladder cancer. However, data from North America rep

Keywords:

Urology
Cisplatin
Adjuvant
Gemcitabine
Medicine
Bladder cancer
Chemotherapy
Internal medicine
combination chemotherapy
Regimen
Carboplatin
Evidence-based medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations